Fixed very-low-dose combination perindopril 2 mg/indapamide 0.625 mg in the treatment of essential arterial hypertension in very elderly patients (≥75 years):: Evaluation over 3 months

被引：4
|
作者：
Castaigne, A
Chalmers, J
Morgan, T
机构：
[1] Hop Henri Mondor, F-94010 Creteil, France
[2] Royal N Shore Hosp, St Leonards, NSW 2065, Australia
[3] Dept Physiol, Parkville, Vic, Australia
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
10.1097/00004872-200006001-00037
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 18 条
  • [1] Fixed low-dose perindopril 2 mg indapamide 0.625 mg combination in very elderly hypertensives
    Forette, B
    JOURNAL OF HUMAN HYPERTENSION, 1999, 13 (03) : 211 - 213
  • [2] Fixed low-dose perindopril 2 mg/indapamide 0.625 mg combination in very elderly hypertensives
    B Forette
    Journal of Human Hypertension, 1999, 13 : 211 - 213
  • [3] Very-low-dose perindopril 2 mg/indapamide 0.625 mg combination gives higher response and normalization rates than losartan 50 mg in the treatment of essential hypertension
    Chanudet, X
    Chau, N
    de Champvallins, M
    JOURNAL OF HYPERTENSION, 2000, 18 : S167 - S167
  • [4] Very-low-dose perindopril 2 mg/indapamide 0.625 mg combination gives higher response and normalization rates than losartan 50 mg in the treatment of essential hypertension
    Chanudet, X
    Chau, NP
    de Champvallins, M
    JOURNAL OF HYPERTENSION, 2000, 18 : S100 - S100
  • [5] Perindopril 2mg/indapamide 0.625mg - Fixed low-dose combination
    McClellan, KJ
    Markham, A
    DRUGS, 1999, 58 (02) : 297 - 302
  • [6] Efficacy over 1 year of a fixed low-dose combination of perindopril 2 mg indapamide 0.625 mg in the treatment of isolated systolic hypertension in subjects aged over 65 years
    Chalmers, J
    Castaigne, A
    Chastang, C
    Feldmann, L
    Guez, D
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 139A - 139A
  • [7] Efficacy of a very low-dose Perindopril 2 mg/Indapamide 0.625 mg on cardiac hypertrophy in hypertensive patients: The Reason project
    De Luca, N
    Safar, ME
    Asmar, R
    Battegay, E
    Benetos, A
    De Leeuw, PW
    Duprez, D
    Fitzgerald, D
    Hedner, T
    Hitzenberger, G
    London, G
    Mallion, JM
    O'Brien, E
    Ollivier, JP
    O'Rourke, MF
    Polonia, J
    Rahn, KH
    Romero, R
    Sever, P
    Trimarco, B
    JOURNAL OF HYPERTENSION, 2002, 20 : S164 - S164
  • [8] Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients:: the PICXEL study rationale and design
    Gosse, P
    Dubourg, O
    Guéret, P
    De Simone, G
    Schmieder, R
    De Leeuw, PW
    Degaute, JP
    Puig, JG
    Karpov, Y
    Magometschnigg, D
    Matos, L
    Amouyel, P
    Asmar, R
    Le Heuzey, JY
    Nieminen, M
    Dahlöf, B
    JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (09) : 653 - 659
  • [9] Very low-dose perindopril 2mg/indapamide 0.625mg reduces left ventricular hypertrophy in hypertensive patients
    De Luca, N
    Safar, ME
    Asmar, R
    Mallion, JM
    O'Rourke, MF
    Romero, R
    Rahn, KH
    Trimarco, B
    EUROPEAN HEART JOURNAL, 2002, 23 : 210 - 210
  • [10] Assessment of the efficacy, safety and tolerability of a fixed dose combination of perindopril/indapamide (2mg/0.625 mg) in adult patients with mild to moderate hypertension
    Desai, AA
    Chandrasekaran, S
    Jain, MM
    Prabhakar, D
    Rajyadhyaksha, GC
    Gawde, AS
    Baliga, VP
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 86A - 86A
12